Patients can now receive general reimbursement for all medicines containing losartan in combination with hydrochlorothiazide. This also includes medicines containing a combination of losartan 100 mg and hydrochlorothiazide 12.5 mg, which were in line to loose reimbursement on 15 November 2010. The reason is that the reimbursement price is now low for all strengths of this combination.
Find more information on the future changes in the box.
For further information, please contact Nikolai Laursen on +45 4488 9102 or
nil@dkma.dk Danish Medicines Agency, 18 October 2010